New Data to be Presented for BioMarin’s VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
March 12, 2024
March 12, 2024
Subscribe to our email alerts for investors to stay informed about the latest developments at BioMarin.